Granahan Investment Management, LLC Xeris Biopharma Holdings, Inc. Transaction History

Granahan Investment Management, LLC

  • $2.38 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.48 - $2.64 $599,765 - $1.07 Million
-405,247 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$2.0 - $2.87 $238,730 - $342,577
-119,365 Reduced 22.75%
405,247 $1.04 Million
Q4 2021

Feb 14, 2022
BUY
$1.8 - $2.93 $944,301 - $1.54 Million
524,612 New
524,612 $1.54 Million

Others Institutions Holding XERS

# of Institutions
143
Shares Held
60M
Call Options Held
148K
Put Options Held
45.7K
View Full List

About Xeris Biopharma Holdings, Inc.

XERS Quotes by TradingView
  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $465M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Granahan Investment Management, LLC Portfolio

Follow Granahan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email